rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    IKT
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Inhibikase at jefferies healthcare conference: phase iii push gains pace
      Nov 16Investing.comIKTJEF
      Inhibikase Therapeutics Announces Third Quarter 2026 Financial Results and Highlights Recent Activity
      Nov 10Yahoo FinanceIKT
      Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026
      Oct 27Yahoo FinanceIKT
      Inhibikase Appoints Scott Wasserman to Board of Directors

      Tipranks Press Release.

      Oct 21The Globe and MailIKT
      Inhibikase appoints Scott Wasserman to board of directors
      Oct 20Investing.comIKT
      Inhibikase Therapeutics Appoints Scott Wasserman to Board of Directors
      Oct 20Yahoo FinanceIKT
      Chardan Initiates Inhibikase Therapeutics at Neutral With $1.50 Price Target
      Oct 13Yahoo FinanceIKT
      Chardan initiates Inhibikase Therapeutics stock with neutral rating
      Oct 13Investing.comIKT
      Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
      Oct 2Yahoo FinanceIKT

      This is the newest page. Registered accounts read further back.